Page 7 - 《中国药房》2022年24期
P. 7

·药事管理·


          国内抗菌药物临床应用分级管理目录与 WHO 抗菌药物 AWaRe

          分级目录的对比分析
                                          Δ

                 1 *
                                                     1
                                                             1
                                                                              1
                                            1
                           1
                                   1
                                                                     2
          杨瑶瑶 ,凌可欣 ,张 翕 ,杜可欣 ,张琬朦 ,胡 琳 ,郑 波 ,管晓东 ,海沙尔江·吾守尔                                       1, 3 # ,史录文  1, 3
         (1. 北京大学药学院药事管理与临床药学系,北京 100191;2. 北京大学第一医院临床药理研究所,北京
          100191;3.北京大学医药管理国际研究中心,北京 100191)
          中图分类号  R95      文献标志码  A      文章编号  1001-0408(2022)24-2945-07
          DOI  10.6039/j.issn.1001-0408.2022.24.01
          摘  要  目的  为我国动态调整抗菌药物临床应用分级管理目录、促进其合理使用提供参考和建议。方法  汇总各省份最新版抗
          菌药物临床应用分级管理目录作为“国家版目录”,与 2021 年 WHO 抗菌药物 AWaRe 分级目录(简称“AWaRe 分级目录”)进行对
          比,描述性统计分析两目录中不同级别抗菌药物品种数及其差异。结果  根据不同的分级原则,国家版目录将262种抗菌药物制
          剂分为非限制(84种)、限制(83种)和特殊使用级(95种),AWaRe分级目录将258种抗菌药物制剂分为可用(87种)、慎用(142种)
          和备用级(29种);两目录共同收录的抗菌药物制剂有182种。在国家版目录中,非限制使用级抗菌药物制剂有36种为可用级,30
          种为慎用级,1种为备用级;限制使用级抗菌药物制剂有7种为可用级,46种为慎用级,3种为备用级;特殊使用级抗菌药物制剂有
          9种为可用级,35种为慎用级,15种为备用级;其中,91种抗菌药物制剂是WHO不推荐使用的(20种)或AWaRe分级目录未收录的
         (71种)。结论  两目录的分级方法在分级原则以及部分药品的级别制定上不尽相同。抗菌药物临床应用分级管理目录是抗菌药
          物管理工作的抓手之一,未来需要开展更多的研究为优化我国抗菌药物分级管理提供充足证据。
          关键词  抗菌药物;分级管理;AWaRe分级目录;中国;世界卫生组织


          Comparative analysis of domestic classification management list for clinical use of antibiotics versus WHO
          AWaRe classification list of antibiotics
                                                            1
                       1
                                    1
                                                 1
                                                                                        1
          YANG Yaoyao ,LING Kexin ,ZHANG Xi ,DU Kexin ,ZHANG Wanmeng ,HU Lin ,ZHENG Bo ,GUAN
                                                                               1
                                                                                                     2
          Xiaodong ,Haishaerjiang·Wushouer ,SHI Luwen   1, 3  (1.  Dept.  of  Pharmacy  Administration  and  Clinical
                  1
                                          1, 3
          Pharmacy,  School  of  Pharmaceutical  Sciences,  Peking  University,  Beijing  100191,  China;2.  Institute  of
          Clinical  Pharmacology,  Peking  University  First  Hospital,  Beijing  100191,  China;3.  International  Research
          Center for Medicinal Administration, Peking University, Beijing 100191, China)
          ABSTRACT   OBJECTIVE  To  provide  reference  and  suggestions  for  dynamic  adjustment  of  classification  management  lists  for
          clinical use of antibiotics and the promotion of rational use of antibiotics. METHODS The latest version of provincial classification
          management  lists  for  clinical  use  of  antibiotics  were  aggregated  into  the “national  list”,  which  was  compared  with  2021  WHO
          AWaRe  classification  list  of  antibiotics (hereinafter  referred  as  to “AWaRe  classification  list”)  to  make  a  descriptive  statistical
          analysis about the number of different classes of antibiotics in the two lists and their differences. RESULTS Based on the different
          classification  principles,  262  kinds  of  antibiotic  preparations  in  the  national  list  were  classified  into  non-restricted (84),  restricted
         (83)  and  highly-restricted  classes (95),  and  258  kinds  in  the  AWaRe  classification  list  were  classified  into  access (87),  watch
         (142) and reserve classes (29); 182 kinds of antibiotic preparations were both included in the two lists. In the national list, among
          the non-restricted antibiotic preparations, 36 kinds belonged to access class, 30 belonged to watch class and 1 belonged to reserve
                                                             class;  among  restricted  antibiotic  preparations,  7  belonged  to
             Δ 基金项目 国家自然科学基金国际(地区)合作与交流项目(No.
                                                             access class, 46 kinds belonged to watch class and 3 belonged
          81861138048);国家自然科学基金面上项目(No.81973294)
                                                             to   reserve   class;   among   highly-restricted   antibiotic
             *第一作者 硕士研究生。研究方向:药事管理。电话:010-
          82805019。E-mail:yyy211anne@163.com                 preparations,  9  belonged  to  access  class,  35  belonged  to
             # 通信作者 助理研究员,博士。研究方向:合理用药与药物经济                  watch  class  and  15  kinds  belonged  to  reserve  class.  Among
          学。电话:010-82805019。E-mail:kaiser@pku.edu.cn         them,  91  kinds  of  antibiotic  preparations  were  not


          中国药房  2022年第33卷第24期                                              China Pharmacy  2022 Vol. 33  No. 24    · 2945 ·
   2   3   4   5   6   7   8   9   10   11   12